266 related articles for article (PubMed ID: 33545822)
1. Hyperthermia treatment of cancer cells by the application of targeted silk/iron oxide composite spheres.
Kucharczyk K; Kaczmarek K; Jozefczak A; Slachcinski M; Mackiewicz A; Dams-Kozlowska H
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111654. PubMed ID: 33545822
[TBL] [Abstract][Full Text] [Related]
2. Composite spheres made of bioengineered spider silk and iron oxide nanoparticles for theranostics applications.
Kucharczyk K; Rybka JD; Hilgendorff M; Krupinski M; Slachcinski M; Mackiewicz A; Giersig M; Dams-Kozlowska H
PLoS One; 2019; 14(7):e0219790. PubMed ID: 31306458
[TBL] [Abstract][Full Text] [Related]
3. Drug affinity and targeted delivery: double functionalization of silk spheres for controlled doxorubicin delivery into Her2-positive cancer cells.
Kucharczyk K; Florczak A; Deptuch T; Penderecka K; Jastrzebska K; Mackiewicz A; Dams-Kozlowska H
J Nanobiotechnology; 2020 Mar; 18(1):56. PubMed ID: 32228620
[TBL] [Abstract][Full Text] [Related]
4. Blending two bioengineered spider silks to develop cancer targeting spheres.
Florczak A; Jastrzebska K; Mackiewicz A; Dams-Kozlowska H
J Mater Chem B; 2017 Apr; 5(16):3000-3011. PubMed ID: 32263992
[TBL] [Abstract][Full Text] [Related]
5. Functionalized spider silk spheres as drug carriers for targeted cancer therapy.
Florczak A; Mackiewicz A; Dams-Kozlowska H
Biomacromolecules; 2014 Aug; 15(8):2971-81. PubMed ID: 24963985
[TBL] [Abstract][Full Text] [Related]
6. Alternating magnetic field-induced hyperthermia increases iron oxide nanoparticle cell association/uptake and flux in blood-brain barrier models.
Dan M; Bae Y; Pittman TA; Yokel RA
Pharm Res; 2015 May; 32(5):1615-25. PubMed ID: 25377069
[TBL] [Abstract][Full Text] [Related]
7. Functionalized silk spheres selectively and effectively deliver a cytotoxic drug to targeted cancer cells in vivo.
Florczak A; Deptuch T; Lewandowska A; Penderecka K; Kramer E; Marszalek A; Mackiewicz A; Dams-Kozlowska H
J Nanobiotechnology; 2020 Dec; 18(1):177. PubMed ID: 33261651
[TBL] [Abstract][Full Text] [Related]
8. Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres.
Florczak A; Mackiewicz A; Dams-Kozlowska H
Int J Nanomedicine; 2019; 14():6855-6865. PubMed ID: 32021156
[TBL] [Abstract][Full Text] [Related]
9. In vivo study of the immune response to bioengineered spider silk spheres.
Deptuch T; Penderecka K; Kaczmarek M; Molenda S; Dams-Kozlowska H
Sci Rep; 2022 Aug; 12(1):13480. PubMed ID: 35931709
[TBL] [Abstract][Full Text] [Related]
10. Highly Optimized Iron Oxide Embedded Poly(Lactic Acid) Nanocomposites for Effective Magnetic Hyperthermia and Biosecurity.
Ryu C; Lee H; Kim H; Hwang S; Hadadian Y; Mohanty A; Park IK; Cho B; Yoon J; Lee JY
Int J Nanomedicine; 2022; 17():31-44. PubMed ID: 35023918
[TBL] [Abstract][Full Text] [Related]
11. Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.
Kozlowska AK; Florczak A; Smialek M; Dondajewska E; Mackiewicz A; Kortylewski M; Dams-Kozlowska H
Acta Biomater; 2017 Sep; 59():221-233. PubMed ID: 28694238
[TBL] [Abstract][Full Text] [Related]
12. Optimization of spider silk sphere formation processing conditions to obtain carriers with controlled characteristics.
Florczak A; Jastrzebska K; Bialas W; Mackiewicz A; Dams-Kozlowska H
J Biomed Mater Res A; 2018 Dec; 106(12):3211-3221. PubMed ID: 30242958
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications.
Kruse AM; Meenach SA; Anderson KW; Hilt JZ
Acta Biomater; 2014 Jun; 10(6):2622-9. PubMed ID: 24486913
[TBL] [Abstract][Full Text] [Related]
14. Bioengineering the spider silk sequence to modify its affinity for drugs.
Kucharczyk K; Weiss M; Jastrzebska K; Luczak M; Ptak A; Kozak M; Mackiewicz A; Dams-Kozlowska H
Int J Nanomedicine; 2018; 13():4247-4261. PubMed ID: 30050299
[TBL] [Abstract][Full Text] [Related]
15. MMPs-responsive silk spheres for controlled drug release within tumor microenvironment.
Kucharczyk K; Florczak A; Kaminska A; Guzniczak N; Sikorska A; Deptuch T; Dams-Kozlowska H
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132016. PubMed ID: 38697442
[TBL] [Abstract][Full Text] [Related]
16.
Ognjanović M; Radović M; Mirković M; Prijović Ž; Puerto Morales MD; Čeh M; Vranješ-Đurić S; Antić B
ACS Appl Mater Interfaces; 2019 Nov; 11(44):41109-41117. PubMed ID: 31610125
[TBL] [Abstract][Full Text] [Related]
17. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer.
Eyvazzadeh N; Shakeri-Zadeh A; Fekrazad R; Amini E; Ghaznavi H; Kamran Kamrava S
Lasers Med Sci; 2017 Sep; 32(7):1469-1477. PubMed ID: 28674789
[TBL] [Abstract][Full Text] [Related]
18. Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer.
Bonvin D; Bastiaansen JAM; Stuber M; Hofmann H; Mionić Ebersold M
Dalton Trans; 2017 Sep; 46(37):12692-12704. PubMed ID: 28914298
[TBL] [Abstract][Full Text] [Related]
19. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
[TBL] [Abstract][Full Text] [Related]
20. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
